Diabetes technology

Accuracy of Real-Time Continuous Glucose Monitoring System in Hospitalized Patients with Diabetes and Chronic Kidney Disease

Diabetes Technol TherPublished Prospective observational study

Authors' conclusion

The Dexcom G6 demonstrated reliable accuracy in hospitalized patients with diabetes and CKD, with better performance in advanced CKD.

Study context

Population
Hospitalized patients with diabetes and chronic kidney disease (CKD); excluded acute kidney injury, active glomerulonephritis, intensive care or hemodialysis1,603 paired values
Participants
52 patients
Exposure
Real-time continuous glucose monitoring (CGM) vs capillary point-of-care (POC) glucose, by estimated glomerular filtration rate (eGFR) category
Outcome
Accuracy of real-time CGM vs POC capillary glucose (MARD, correlation, Bland-Altman, consensus error grid)
Methodological detailsdiagnostic accuracy, paired CGM vs capillary POC glucose
  • Diagnostic accuracy
  • Paired CGM vs capillary POC glucose

Main finding

As reported in the abstract

MARD
GroupValuePaired values
G1-219.4%752
G315.5%571
G4-513.5%280

Value

G1-219.4%
G315.5%
G4-513.5%

Paired values

G1-2752
G3571
G4-5280
  • G1-2 vs G3: P < 0.001 — across the three eGFR groups
Overall mean absolute relative difference (MARD)
17.0%
CGM vs POC glucose correlation
r = 0.91, P < 0.001

Observational data: associations, not effects.

Further findings

Bland-Altman agreement

Smaller bias and narrower limits of agreement in advanced CKD

Consensus error grid

Values within clinically acceptable zones
>99%

Original publication

Accuracy of Real-Time Continuous Glucose Monitoring System in Hospitalized Patients with Diabetes and Chronic Kidney Disease. Diabetes Technol Ther. Published 16 February 2026. doi:10.1177/15209156261423902

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.